Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.23 | 5e-06 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-06 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |